CIDRAP newsletters options
Data from the Wellcome Monitor survey of UK citizens reveal that negative views of vaccination are tied to having poor knowledge about the role of antibiotics for treating infections, according to a study today in Vaccine.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
In Shanghai, officials maintain no one has died from Omicron—an assertion being challenged.
Compared with a third dose, fourth-dose protection was 64% against severe disease and 76% against death.
Data suggest 4CMenB protection against gonorrhea and support the feasibility of a gonococcal vaccine.
In its first evaluation of COVID-19 exposures among US healthcare professionals (HCPs) over the first year of the pandemic, the Centers for Disease Control and Prevention (CDC) reports that most HCPs were likely infected at work rather than in the community.
COVID-19 exposed existing US public health weaknesses, especially along racial lines.
The CDC extends the mask order for public transit by 2 weeks and revamps international travel alerts.
Cefiderocol and ceftazidime-avibactam were selected to be part of a novel pilot project.
Two new studies describe benefits of the monoclonal antibody (mAb) treatment casirivimab-imdevimab in adult COVID-19 outpatients, both suggesting lower rates of hospitalization, intensive care unit (ICU) admission, and death in an era dominated by the Delta variant.
A large-scale analysis reveals that the prevalence of antimicrobial resistance (AMR) has remained stable for Campylobacter in the United States and United Kingdom in recent years, suggesting that antibiotic stewardship efforts have not made a large impact, according to a new study in Antimicrobial Agents and Chemotherapy.
Recent evidence shows one-dose regimens perform just as well as two- or three-dose schedules.
Researchers say 44% of the population was infected by November 2021, with wide regional variations.
Cases are rising in eastern states where BA.2 subvariant proportions are very high. Globally, COVID cases passed the 500 million mark today.
Approximately 2.4 out of every 1,000 patients hospitalized with COVID-19 developed myocarditis, an inflammation of the heart muscle that typically follows viral infections, according to an international study published yesterday in the American Heart Association (AHA) journal Circulation.
When including possible myocarditis cases, the rate increases to 4.1 per 1,000 hospitalized patients.
A randomized clinical trial found that a shorter antimicrobial prophylaxis (AMP) duration for "clean" orthopedic surgery (scheduled procedures not involving complications like open wounds) was non-inferior to a longer duration in preventing healthcare-associated infections (HAIs), Japanese researchers reported today in JAMA Network Open.
Two outbreaks on turkey farms in Minnesota bring that state's total to 28, affecting almost 1.4 million turkeys.
Gram stain–guided therapy safely cut broad-spectrum antibiotics in patients with ventilator-associated pneumonia.
Foreign-born essential workers were at almost quadruple the risk of hospitalization and ICU care.
Also, Philadelphia reinstates a mask mandate, the first major US city to do so.
